Cetera Investment Advisers
ABMD

Cetera Investment Advisers’s Abiomed Inc ABMD Stock Holding History

Cetera Investment Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,809
Closed -$1.43M – 2186
2022
Q3 		$1.43M Sell
5,809
-80
-1% -$21.6K 0.03% 576
2022
Q2 		$1.46M Sell
5,889
-586
-9% -$158K 0.02% 637
2022
Q1 		$2.15M Buy
6,475
+4,553
+237% +$1.4M 0.03% 539
2021
Q4 		$690K Buy
1,922
+101
+6% +$34.1K 0.01% 992
2021
Q3 		$593K Buy
1,821
+740
+68% +$251K 0.01% 1040
2021
Q2 		$337K Buy
1,081
+379
+54% +$116K 0.01% 1347
2021
Q1 		$224K Sell
702
-374
-35% -$120K ﹤0.01% 1413
2020
Q4 		$349K Buy
+1,076
New +$298K 0.01% 1154

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cetera Investment Advisers's ABMD Position: Q4 2022 in Review

Cetera Investment Advisers sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5,809 shares — an estimated $1.43M sold.

Cetera Investment Advisers first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $2.15M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Cetera Investment Advisers reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Cetera Investment Advisers sold 5,809 Abiomed Inc shares in Q4 2022, an estimated $1.43M.
  • Cetera Investment Advisers first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • Cetera Investment Advisers's Abiomed Inc position peaked at $2.15M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Cetera Investment Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.